Facebook Pixel India Free From Avian Influenza | Bio Spectrum - Business - इस कहानी को Magzter.com पर पढ़ें

कोशिश गोल्ड - मुक्त

India Free From Avian Influenza

Bio Spectrum

|

August 2017

Strict surveillance including culling, disinfection and clean-up have worked remarkably in making India free from Avian Influenza. Specified actions formulated by the Ministry of Health still needs to be taken up regularly.

- Kalyani Sharma

India Free From Avian Influenza

India had reported outbreaks of Highly Pathogenic Avian Influenza (H5N1 and H5N8) at various places like Gwalior (Madhya Pradesh), Rajpura (Punjab), Hissar (Haryana), Bellary (Karnataka), Allappuzha and Kottayam (Kerala) and Ahmedabad (Gujarat) during October 2016 to February 2017.

All the outbreaks of Avian Influenza (HPAI) mentioned above were notified to World Organisation for Animal Health (OIE), is an intergovernmental organization coordinating, supporting and promoting animal disease control, and the control and containment operations were carried out as per the Action Plan on Preparedness, Control and Containment of Avian Influenza. Surveillance was carried out throughout the country and around the areas of the outbreaks since completion of the operation (including culling, disinfection and clean-up) and surveillance in the states showed no evidence of presence of Avian Influenza Virus.

India is now free from highly contagious Avian Influenza (H5N1) or bird flu. Department of Animal Husbandry, Dairying and Fisheries in the Union Ministry of Agriculture and Farmers Welfare made this announcement as no outbreak of Avian Influenza (H5N1) was reported in the country after the last notified outbreak at Humnabad, Bidar district, Karnataka in June 2016.

According to the statement given by Union agriculture ministry, "India has declared itself free from Avian Influenza (H5N8 and H5N1) from June 6, 2017 and notified the same to the World Organisation for Animal Health (OIE).”

The statement also says, “Various control measures like stamping out of entire poultry population including destruction of eggs, litter, feed and other infected materials were adopted.”

About Avian Influenza (AI)

AI or bird flu is an infectious viral disease of birds which can sometimes spread to domestic poultry and cause large-scale outbreaks of serious disease.

Bio Spectrum

यह कहानी Bio Spectrum के August 2017 संस्करण से ली गई है।

हजारों चुनिंदा प्रीमियम कहानियों और 10,000 से अधिक पत्रिकाओं और समाचार पत्रों तक पहुंचने के लिए मैगज़्टर गोल्ड की सदस्यता लें।

क्या आप पहले से ही ग्राहक हैं?

Bio Spectrum से और कहानियाँ

Bio Spectrum

Bio Spectrum

MAHE teams up with OpenAI to integrate AI to enhance outcomes

Manipal Academy of Higher Education (MAHE), an Institution of Eminence Deemed to be University in Karnataka, has partnered with OpenAI to integrate advanced artificial intelligence (AI) tools across teaching, research, and academic administration.

time to read

1 min

April 2026

Bio Spectrum

Bio Spectrum

Jubilant Bhartia Foundation & McGill University to launch CoE in AI education

The Jubilant Bhartia Foundation in collaboration with McGill University (Canada), has signed a Memorandum of Understanding (MoU) to create the Centre of Excellence (CoE) in artificial intelligence (AI) Education and Research.

time to read

1 min

April 2026

Bio Spectrum

Bio Spectrum

Heeding Auditory Warning Signs

By 2050, nearly 2.5 billion people are projected to have some degree of hearing loss, and more than 700 million might require hearing rehabilitation. That's according to the World Health Organization (WHO).

time to read

2 mins

April 2026

Bio Spectrum

Bio Spectrum

Botanic Healthcare on-boards Narahari Naidu as Group Chief Financial Officer

Secundarabad-based Botanic Healthcare, a globally leading nutraceutical company, has announced the appointment of Narahari Naidu as its Group Chief Financial Officer (CFO).

time to read

1 min

April 2026

Bio Spectrum

Bio Spectrum

Paras Health ropes in Balkishan Sharma as Group CHRO and Business Transformation Officer

Paras Health has announced the appointment of Balkishan Sharma as Group Chief Human Resources Officer (Group CHRO) and Business Transformation Officer.

time to read

1 min

April 2026

Bio Spectrum

Bio Spectrum

Parse Biosciences unveils Evercode Whole Transcriptome V4 with shorter workflow

Parse Biosciences, a Qiagen company, has announced the launch of the new Evercode Whole Transcriptome v4 product line, delivering expanded scalability, higher sensitivity and a simplified workflow for single-cell RNA sequencing. Evercode v4 supports extraordinary scalability of up to five million cells and 384 samples in a single run, enabling researchers

time to read

1 min

April 2026

Bio Spectrum

Bio Spectrum

UK deploys new bone scanners to help prevent fractures

Tens of thousands of patients at risk of osteoporosis and other bone conditions will get faster access to vital bone scans, as 20 new scanners are rolled out across England.

time to read

1 min

April 2026

Bio Spectrum

Bio Spectrum

Cytiva expands Fast Trak process development and validation services facility in India

Cytiva, a Danaher company and a leader in the life sciences industry, has inaugurated an expanded facility for Fast Trak process development (PD) and validation services in Bengaluru.

time to read

1 min

April 2026

Bio Spectrum

Bio Spectrum

ΑΙ TAKES INDIAN PHARMA REINS

The Indian pharmaceutical sector, one of the largest in the world, is undergoing a strategic transformation in the way it operates. As artificial intelligence (AI) gains prominence across the industry, companies are actively adopting Al-driven solutions to enhance efficiency across the entire pharmaceutical ecosystem. Organisations are investing in AI training programmes to keep their workforce future-ready, foster innovation, strengthen supply chains, and transition away from manual record-keeping. In this industry analysis, experts share their perspectives on how AI is shaping the future of the pharma sector.

time to read

10 mins

April 2026

Bio Spectrum

NIH halts arm of clinical trial evaluating potential stroke treatment

The National Institutes of Health (NIH) in the US has stopped an investigational treatment arm of the Comparison of Anti-coagulation and Anti-platelet Therapies for Intracranial Vascular Atherostenosis (CAPTIVA) study, following a regular review by the Data Safety and Monitoring Board (DSMB).

time to read

1 min

April 2026

Translate

Share

-
+

Change font size